Synergistic interactions of methanolic extract of Acacia mearnsii de wild. with antibiotics against bacteria of clinical relevance

International Journal of Molecular Sciences

Volumn 13, Issue 7, 2012, Pages 8915-8932

  Olajuyigbe, Olufunmiso O ^a   Afolayan, Anthony J ^a  

^a UNIVERSITY OF FORT HARE   (South Africa)

Author keywords

Acacia mearnsii; Checkerboard assay; Drug herbal interaction; Multi drug resistance; Synergistic effects

Indexed keywords

ACACIA MEARNSII EXTRACT; AMOXICILLIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CHLORAMPHENICOL; CIPROFLOXACIN; ERYTHROMYCIN; KANAMYCIN; METHANOL; METRONIDAZOLE; NALIDIXIC ACID; PLANT EXTRACT; TETRACYCLINE; UNCLASSIFIED DRUG;

ACACIA MEARNSII; AGAR DIFFUSION; ANTIBIOTIC SENSITIVITY; ARTICLE; ASSAY; BACILLUS SUBTILIS; BACTERICIDAL ACTIVITY; BARK; CHECKERBOARD ASSAY; DRUG POTENTIATION; ENTEROBACTER CLOACAE; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; HERB DRUG INTERACTION; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROTEUS VULGARIS; SHIGELLA SONNEI; STAPHYLOCOCCUS AUREUS; ACACIA; AGONISTS; BACTERIUM; CHEMISTRY; GROWTH, DEVELOPMENT AND AGING; METABOLISM;

ACACIA MEARNSII; PROTEUS VULGARIS; STAPHYLOCOCCUS AUREUS;

ACACIA; ANTI-BACTERIAL AGENTS; BACTERIA; DRUG SYNERGISM; METHANOL; PLANT EXTRACTS;

EID: 84864356152     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms13078915     Document Type: Article

References (90)

1. Murray, C.J.; Lopez, A.D. Mortality by cause for eight regions of the world: Global burden of disease study. Lancet 1997, 349, 1269-1276.
2. Kochanek, K.D.; Murphy, S.L.; Anderson, R.N.; Scott, C.; Division of Vital Statistics. Deaths: Final Data for 2002; National Vital Statistics Report, Volume 53, No. 5; National Center for Health Statistics: Hyattsville, MD, USA, 2004.
3. World Health Organization (WHO). The World Health Report 2003: Shaping the Future; WHO: Geneva, Switzerland, 2003.
4. World Health Organization (WHO). Report on Infectious Diseases. Removing Obstacles to Healthy Development; WHO: Geneva, Switzerland, 1999.
5. World Health Organization (WHO). The World Health Report 2002: Reducing Risks, Promoting Healthy Life; WHO: Geneva, Switzerland, 2002.
6. Hotchkiss, R.S.; Karl, I.E. The pathophysiology and treatment of sepsis. N. Engl. J. Med. 2003, 348, 138-150.
7. Bone, R.C.; Balk, R.A.; Cerra, F.B.; Dellinger, R.P.; Fein, A.M.; Knaus, W.A.; Schein, R.M.; Sibbald, W.J. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee, American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101, 1644-1655.
8. Kondo, S.; Sattaponpan, C.; Phongpaichit, S.; Srijan, A.; Itharat, A. Antibacterial activity of Thai medicinal plants Pikutbenjakul. J. Med. Assoc. Thail. 2010, 93, S131-S135.
9. Peters, N.K.; Dixon, D.M.; Holland, S.M.; Fauci, A.S. The research agenda of the National Institute of Allergy and Infectious Diseases for Antimicrobial Resistance. J. Infect. Dis. 2008, 197, 1087-1093.
10. Davies, J. Inactivation of antibiotics and the dissemination of resistance genes. Science 1994, 264, 375-382.
11. Service, R.F. Antibiotics that resist resistance. Science 1995, 270, 724-727.
12. Armstrong, D.; Neu, H.; Peterson, L.R.; Tomasz, A. The prospects of treatment failure in the chemotherapy of infectious diseases in the 1990s. Microb. Drug Resist. 1995, 1, 1-4.
13. Wenzel, R.P.; Edmond, M.B. Managing antibiotic resistance. N. Engl. J. Med. 2000, 343, 1961-1963.
14. D'Costa, V.M.; McGrann, K.M.; Hughes, D.W.; Wright, G.D. Sampling the antibiotic resistome. Science 2006, 311, 374-377.
15. DeGirolani, P.C.; Eliopoulos, G. Antimicrobial susceptibility tests and their role in therapeutic drug monitoring. Clin. Lab. Med. 1987, 7, 499-513.
16. Isenberg, H.D. Antimicrobial susceptibility testing: A critical evaluation. J. Antimicrob. Chemother. 1988, 22, 73-86.
17. Peterson, L.R.; Shanholtzer, C.J. Tests for bactericidal effects of antimicrobial agents: Technical performance and clinical relevance. Clin. Microbiol. Rev. 1992, 5, 420-432.
18. Spellberg, B.; Powers, J.H.; Brass, E.P.; Miller, L.G.; Edwards, J.E., Jr. Trends in antimicrobial drug development: Implications for the future. Clin. Infect. Dis. 2004, 38, 1279-1286.
19. Gilbert, D.N.; Edwards, J.E., Jr. Is there hope for the prevention of future antimicrobial shortages? Clin. Infect. Dis. 2002, 35, 215-216.
20. Shlaes, D.M.; Moellering, R.C., Jr. The United States Food and Drug Administration and the end of antibiotics. Clin. Infect. Dis. 2002, 3, 4420-4422.
21. Smolinski, M.S.; Hamburg, M.A.; Lederberg, J. Microbial Threats to Health: Emergence, Detection, and Response; National Academy Press: Washington, DC, USA, 2003; Volume 181.
22. DiMasi, J.A.; Hansen, R.W.; Grabowski, H.G. The price of innovation: New estimates of drug development costs. J. Health Econ. 2003, 22, 151-185.
23. Projan, S.J. Why is Big Pharma getting out of antibacterial drug discovery? Curr. Opin. Microbiol. 2003, 6, 427-430.
24. Lewis, W.H.; Elvin-Lewis, M. Basic Quantitative and Experimental Research Phases of Future Ethnobotany with Reference to the Medicinal Plants of South America. In Ethnobotany and the Search for New Drugs; Chadwick, D.J., Marsh, J., Eds.; John Wiley and Sons: New York, NY, USA, 1994; pp. 60-78.
25. Elvin-Lewis, M.; Lewis, W.H. New Concepts and Medical and Dental Ethnobotany. In Ethnobotany, Evolution of a Discipline; Schultes, R., von Reis, S., Eds.; Dioscorides Press: Portland, OR, USA, 1995; pp. 303-310.
26. Juliani, H.R.; Simon, J.E. Antioxidant Activity of Basil. In Trends in New Crops and New Uses; Janick, J., Whipkey, A., Eds.; ASHS Press: Alexandria, VA, USA, 2002; pp. 575-579.
27. Falerio, M.L.; Miguel, M.G.; Laderio, F.; Venâncio, F.; Tavares, R.; Brito, J.C.; Figueiredo, A.C.; Barroso, J.G.; Pedro, L.G. Antimicrobial activity of essential oils isolated from Portuguese endemic species of Thymus. Lett. Appl. Microbiol. 2003, 36, 35-40.
28. Kalemba, D.; Kunicka, A. Antibacterial and antifungal properties of essential oils. Curr. Med. Chem. 2003, 10, 813-829.
29. Lu, Y.; Zhao, Y.P.; Wang, Z.C.; Chen, S.Y.; Fu, C.X. Composition and antimicrobial activity of the essential oil of Actinidia macrosperma from China. Nat. Prod. Res. 2007, 21, 227-233.
30. Mbwambo, Z.H.; Moshi, M.J.; Masimba, P.J.; Kapingu, M.C.; Nondo, R.S. Antimicrobial activity and brine shrimp toxicity of extracts of Terminalia brownii roots and stem. BMC Complement. Altern. Med. 2007, 7, doi:10.1186/1472-6882-7-9.
31. Kassler, W.J.; Blanc, P.; Greenblatt, R. The use of medicinal herbs by human immunodeficiency virus-infected patients. Arch. Int. Med. 1991, 151, 2281-2288.
32. Buchness, M.R. Alternative medicine and dermatology. Semin. Cutan. Med. Surg. 1998, 17, 284-290.
33. Donaldson, K. Introduction to the healing herbs. ORL Head Neck Nurs. 1998, 16, 9-16.
34. Borchers, A.T.; Hackman, R.M.; Keen, C.L.; Stern, J.S.; Gershwin, M.E. Complementary medicine, a review of immunomodulatory effects of Chinese herbal medicines. Am. J. Clin. Nutr. 1997, 66, 1302-1312.
35. Cherry, M. South Africa-serious about biodiversity science. PLoS Biol. 2005, 3, doi:10.1371/journal.pbio.0030145.
36. Shah, P.M. The need for new therapeutic agents: What is in the pipeline? Clin. Microbiol. Infect. 2005, 11, 36-42.
37. Machado, T.B.; Pinto, A.V.; Pinto, M.C.; Leal, I.C.; Silva, M.G.; Amaral, A.C.; Kuster, R.M.; Netto-dosSantos, K.R. In vitro activity of Brazilian medicinal plants, naturally occurring naphthoquinones and their analogues, against methicillin-resistant Staphylococcus aureus. Int. J. Antimicrob. Agents 2003, 21, 279-284.
38. Zaidan, M.R.; Noor, R.A.; Badrul, A.R.; Adlin, A.; Norazah, A.; Zakiah, I. In vitro screening of five local medicinal plants for antibacterial activity using disc diffusion method. Trop. Biomed. 2005, 22, 165-170.
39. Saklani, A.; Kutty, S.K. Plant-derived compounds in clinical trials. Drug Discov. Today 2008, 13, 161-171.
40. Fabricant, D.S.; Farnsworth, N.R. The value of plants used in traditional medicine for drug discovery. Environ. Health Perspect. 2001, 109 (Suppl. 1), 69-75.
41. Guinet, P.; Vassal, J. Hypotheses on the differentiation of the major groups in the genus Acacia (Leguminosae). Kew Bull. 1978, 32, 509-527.
42. Ross, J.H. An analysis of the African Acacia species: Their distribution, possible origins and relationships. Bothalia 1981, 13, 389-413.
43. Sherry, S.P. The Black Wattle (Acacia mearnsii De Wild); University of Natal Press: Pietermaritzburg, South Africa, 1971.
44. Olajuyigbe, O.O.; Afolayan, A.J. In vitro antibacterial activities of crude aqueous and ethanolic extracts of Acacia mearnsii De Wild. Afr. J. Pharm. Pharmacol. 2011, 5, 1234-1240.
45. Clinical and Laboratory Standard Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing Eighteenth Informational Supplement, M100-S18; CLSI: Wayne, PA, USA, 2008.
46. Eliopoulos, G.M.; Eliopoulos, C.T. Antibiotic combinations: Should they be tested? Clin. Microbiol. Rev. 1988, 1, 139-56.
47. Giertsen, E.; Scheie, A.A.; Rolla, G. Inhibition of plaque formation and plaque acidogenicity by zinc and chlorhexidine combinations. Scand. J. Dent. Res. 1988, 96, 541-550.
48. Grytten, J.; Scheie, A.A.; Giertsen, E. Synergistic antibacterial effects of copper and hexetidine against Streptococcus sobrinus and Streptococcus sanguis. Acta Odontol. Scand. 1988, 46, 181-183.
49. Isenberg, H.D. Synergism Testing: Broth Microdilution Checkerboard and Broth Macrodilution Methods. In Clinical Microbiology Procedures Handbook, 2th ed.; American Society Microbiology: Washington, DC, USA, 1992.
50. Bhusal, Y.; Shiohira, C.M.; Yamane, N. Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis. Int. J. Antimicrob. Agents 2005, 26, 292-297.
51. Petersen, P.J.; Labthavikul, P.; Jones, C.H.; Bradford, P.A. In vitro antibacterial activities of tigecycline in combination with other antimicrobial agents determined by chequerboard and time-kill kinetic analysis. J. Antimicrob. Chemother. 2006, 57, 573-576.
52. Kamatou, G.P.P.; Viljoen, A.M.; van Vuuren, S.F.; van Zyl, R.L. In vitro evidence of antimicrobial synergy between Salvia chamelaeagnea and Leonotis leonurus. S. Afr. J. Bot. 2006, 72, 634-636.
53. Rybak, M.J.; McGrath, B.J. Combination antimicrobial therapy for bacterial infections. Guidelines for the clinician. Drugs 1996, 52, 390-405.
54. Marr, K.A.; Boeckh, M.; Carter, R.A.; Kim, H.W.; Corey, L. Combination antifungal therapy for invasive aspergillosis. Clin. Infect. Dis. 2004, 39, 797-802.
55. Horsburgh, C.R., Jr.; Feldman, S.; Ridzon, R. Practice guidelines for the treatment of tuberculosis. Clin. Infect. Dis. 2000, 31, 633-639.
56. Berenbaum, M.C. Correlations between methods for measurement of synergy. J. Infect. Dis. 1980, 142, 476-480.
57. Hall, M.J.; Middleton, R.F.; Westmacott, D. The fractional inhibitory concentration (FIC) index as a measure of synergy. J. Antimicrob. Chemother. 1983, 11, 427-433.
58. Betoni, J.E.; Mantovani, R.P.; Barbosa, L.N.; di Stasi, L.C.; Junior, A.F. Synergism between plant extract and antimicrobial drugs used on Staphylococcus aureus diseases. Mem. Inst. Oswaldo Cruz 2006, 101, 387-390.
59. Yang, Z.C.; Wang, B.C.; Yang, X.S.; Wang, Q.; Ran, L. The synergistic activity of antibiotics combined with eight traditional Chinese medicines against two different strains of Staphylococcus aureus. Colloids Surf. B Biointerfaces 2005, 41, 79-81.
60. Braga, LC.; Leite, A.A.M.; Xavier, K.G.S.; Takahashi, J.A.; Bemquerer, M.P.; Chartone-Souza, B.; Nascimento, A.M.A. Synergistic interaction between pomegranate extract and antibiotics against Staphylococcus aureus. Can. J. Microbiol. 2005, 51, 541-547.
61. Kumar, A.S.; Venkateshwaran, K.; Vanitha, J.; Saravanan, V.S.; Ganesh, M.; Vasudevan, M.; Sivakumar, T. Synergistic activity of methanolic extract of Thespesia populnea (Malvaceae) flowers with oxytetracycline. Bangladesh J. Pharmacol. 2009, 4, 13-16.
62. Aiyegoro, O.; Adewusi, A.; Oyedemi, S.; Akinpelu, D.; Okoh, A. Interactions of antibiotics and methanolic crude extracts of Afzelia africana (Smith.) against drug resistance bacterial isolates. Int. J. Mol. Sci. 2011, 12, 4477-4487.
63. Pei, R.S.; Zhou, F.; Ji, B.P.; Xu, J. Evaluation of combined antibacterial effects of eugenol, cinnamaldehyde, thymol, carvacrol against E. coli with an improved method. J. Food Sci. 2009, 74, M379-M383.
64. Cushnie, T.P.T.; Lamb, A.J. Antimicrobial activity of flavonoids. Int. J. Antimicrob. Agents 2005, 26, 343-356.
65. Sato, Y.; Shibata, H.; Arai, T.; Yamamoto, A.; Okimura, Y.; Arakaki, N.; Higuti, T. Variation in synergistic activity by flavone and its related compounds on the increased susceptibility of various strains of methicillin-resistant Staphylococcus aureus to β-lactam antibiotics. Int. J. Antimicrob. Agents 2004, 24, 226-233.
66. Dickson, R.A.; Houghton, P.J.; Hylands, P.J.; Gibbons, S. Antimicrobial, resistance-modifying effects, antioxidant and free radical scavenging activities of Mezoneuron benthamianum Baill, Securinega virosa Roxb. and Wild. and Microglossa pyrifolia Lam. Phytother. Res. 2006, 20, 41-45.
67. Sibanda, T.; Okoh, A.I. The challenges of overcoming antibiotic resistance: Plant extracts as potential sources of antimicrobial and resistance modifying agents. Afr. J. Biotechnol. 2007, 6, 2886-2896.
68. Gibbons, S. Phytochemicals for bacterial resistance: Strengths, weaknesses and opportunities. Planta Med. 2008, 74, 594-602.
69. Phillipson, J.D.; O'Neill, M.J. New leads to the treatment of protozoal infections based on natural product molecules. Acta Pharm. Nord. 1987, 1, 131-144.
70. Tsuchiya, H.; Sato, M.; Miyazaki, T.; Fujiwara, S.; Tanigaki, S.; Ohyama, M.; Tanaka, T.; Iinuma, M. Comparative study on the antibacterial activity of phytochemical flavonones against methicillin-resistant Staphylococcus aureus. J. Ethnopharmacol. 1996, 50, 27-34.
71. Prasad, R.N.; Viswanathan, S.; Devi, J.R.; Nayak, V.; Swetha, V.C.; Archana, B.R.; Parathasarathy, N.; Rajkumar, J. Preliminary phytochemical screening and microbial activity of Samaea saman. J. Med. Plant Res. 2008, 2, 268-270.
72. Abukakar, M.G.; Ukwuani, A.N.; Shehu, R.A. Phytochemical screening and antibacterial activity of Tamarindus indica pulp extract. Asian J. Biochem. 2008, 3, 134-138.
73. Esinome, C.O.; Iroha, I.R.; Ibezim, E.C.; Okeh, C.O.; Okpana, E.M. In vitro evaluation of the interaction between tea extracts and penicillin G against Staphylococcus aureus. Afr. J. Biotechnol. 2006, 5, 1082-1086.
74. Vaara, M. Agents, that increase the permeability of the outer membrane. Microbiol. Rev. 1992, 56, 395-411.
75. Haukland, H.H.; Ulvatne, H.; Sandvik, K.; Vorland, L.H. The antimicrobial peptides lactoferricin B and magainin 2 cross over the bacterial cytoplasmic membrane and reside in the cytoplasm. FEBS Lett. 2001, 508, 389-393.
76. Aburjai, T.; Darwish, R.M.; Al-Khalil, S.; Mahafzah, A.; Al-Abbadi, A. Screening of antibiotic resistant inhibitors from local plant materials against two different strains of Pseudomonas aeruginosa. J. Ethnopharmacol. 2001, 76, 39-44.
77. Darwish, R.M.; Aburjai, T.; Al-Khalil, S.; Mahafzah, A. Screening of antibiotic resistant inhibitors from local plant materials against two different strains of Staphylococcus aureus. J. Ethnopharmacol. 2002, 79, 359-364.
78. Hemaiswarya, S.; Kruthiventi, A.K.; Doble, M. Synergism between natural products and antibiotics against infectious diseases. Phytomedicine 2008, 15, 639-652.
79. Zhao, W.H.; Hu, Z.Q.; Okubo, S.; Hara, Y.; Shimamura, T. Mechanism of synergy between epigallochatechin gallate and β-lactams against methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 2001, 45, 1737-1742.
80. Gunics, G.; Farkas, S.; Motohashi, N.; Shah, A.; Harsukh, G.; Kawase, M.; Molnár, J. Interaction between 3,5-diacetyl-1,4-dihydropyridines and ampicillin, and erythromycin on different E. coli strains. Int. J. Antimicrob. Agents 2002, 20, 227-229.
81. Wagner, H.; Ulrich-Merzenich, G. Synergy research: Approaching a new generation of phytopharmaceuticals. Phytomedicine 2009, 16, 97-110.
82. Coutinho, H.D.M.; Costa, J.G.M.; Falcão-Silva, V.S.; Lima, E.O.; Siqueira, J.P., Jr. Enhancement of the antibiotic activity against a multi-resistant Escherichia coli by Mentha arvensis L. and chlorpromazine. Chemotherapy 2008, 54, 328-330.
83. Basri, D.F.; Fan, S.H. The potential of aqueous and acetone extracts of galls of Queercus infectoria as antibacterial agents. Indian J. Pharmacol. 2005, 37, 26-29.
84. European Committee for Antimicrobial Susceptibility Testing (EUCAST). Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by agar dilution. Clin. Microbiol. Infect. 2000, 6, 509-515.
85. National Committee for Clinical Laboratory Standards (NCCLS). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, 4th ed.; Approved Standard M7-A4; NCCLS: Wayne, PA, USA, 1997.
86. Richard, S.; Lynn, S.M.; Avery, C.G. Antimicrobial Susceptibility Testing Protocols; CRC Press: New York, NY, USA, 2007.
87. Cheesbrough, M. Medical Laboratory Manual for Tropical Countries, 2th ed.; Butterworth-Heinemann: Cambridge, UK, 1987; pp. 2-392.
88. BSAC Disc Diffusion Method for Antimicrobial Susceptibility Testing, Version 2.1.2; British Society of Antimicrobial Chemotherapy: Birmingham, UK, 2002.
89. Bauer, A.W.; Kirby, W.M.; Sherris, J.C.; Truck, M. Antibiotic susceptibility testing by a standardized single disk method. Am. J. Clin. Pathol. 1966, 45, 493-496.
90. Mandal, S.; Mandal, M.D.; Pal, N.K. Evaluation of combination effect of ciprofloxacin and cefazolin against Salmonella enteric serovar typhi isolates by in vitro methods. Calicut Med. J. 2004, 2, e2